Evidence map›Paper›PMID 40317599›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Reduced myelin contributes to cognitive impairment in patients with monogenic small vessel disease.

Jannis Denecke, Anna Dewenter, Jongho Lee, Nicolai Franzmeier, Carolina Valentim, Anna Kopczak, Martin Dichgans, Lukas Pirpamer, Benno Gesierich, Marco Duering and 1 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Brain endothelial GαEBioMedicine · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Reduced myelin contributes to cognitive impairment in patients with monogenic small vessel disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jannis DeneckeInstitute for Stroke and Dementia Research (ISD), LMU University Hospital, Munich, Germany.
Anna DewenterInstitute for Stroke and Dementia Research (ISD), LMU University Hospital, Munich, Germany.
Jongho LeeLaboratory for Imaging Science and Technology, Department of Electrical and Computer Engineering, Seoul, Republic of Korea.
Nicolai FranzmeierInstitute for Stroke and Dementia Research (ISD), LMU University Hospital, Munich, Germany.
Carolina ValentimInstitute for Stroke and Dementia Research (ISD), LMU University Hospital, Munich, Germany.
Anna KopczakInstitute for Stroke and Dementia Research (ISD), LMU University Hospital, Munich, Germany.
Martin DichgansInstitute for Stroke and Dementia Research (ISD), LMU University Hospital, Munich, Germany.
Lukas PirpamerMedical Image Analysis Center (MIAC) and Department of Biomedical Engineering, University of Basel, Basel, Switzerland.
Benno GesierichInstitute for Stroke and Dementia Research (ISD), LMU University Hospital, Munich, Germany.
Marco DueringInstitute for Stroke and Dementia Research (ISD), LMU University Hospital, Munich, Germany.
Michael EwersInstitute for Stroke and Dementia Research (ISD), LMU University Hospital, Munich, Germany.ORCID 0000-0001-5231-1714

Funding

Bundesministerium für Bildung und Forschung 01KU2203HORIZON EUROPE Framework Programme 666881
6 · The paper itself

Abstract

introductionMyelin is pivotal for signal transfer and thus cognition. Cerebral small vessel disease (cSVD) is primarily associated with white matter (WM) lesions and diffusion changes; however, myelin alterations and related cognitive impairments in cSVD remain unclear.

methodsWe included 64 patients with familial cSVD (i.e., cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy [CADASIL]) and 20 cognitively unimpaired individuals. χ separation applied to susceptibility weighted imaging was used to assess myelin and iron within WM hyperintensities, normal appearing WM, and two strategic fiber tracts. Diffusion-based mean diffusivity and free water were analyzed for comparisons. Cognitive impairment was assessed by the Trail Making Test.

resultsCADASIL patients showed reduced myelin within WM hyperintensities and its penumbra in the normal appearing WM. Myelin was moderately correlated with diffusion and iron changes and associated with slower processing speed controlled for diffusion and iron alterations. DISCUSSION: Myelin constitutes WM alterations distinct from diffusion changes and substantially contributes to explaining cognitive impairment in cSVD. HIGHLIGHTS: χ-negative magnetic resonance signal was reduced within white matter hyperintensities and normal appearing white matter in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, suggesting widespread myelin decreases due to cerebral small vessel disease (cSVD). χ-negative values were only moderately associated with diffusion tensor imaging derived indices including free water and mean diffusivity, suggesting that χ separation depicts distinct microstructural changes in cSVD. Alterations in χ-negative values made a unique contribution to explain processing speed impairment, even when controlled for diffusion and iron changes.

Indexed as

CADASILCerebral Small Vessel DiseasesCognitive DysfunctionMyelin SheathWhite MatterAgedDiffusion Tensor ImagingFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedNeuropsychological Testscerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathychi separationdiffusion magnetic resonance imagingsusceptibility mappingwhite matter hyperintensities

Identifiers

PMID40317599
PMCPMC12046978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.